Compound Detail
CHEMBL2164450
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2164450 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | LKLRNWHRLUKWFJ-UHFFFAOYSA-N |
2
Targets
4
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
585.2
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 4 meas. best 10.6
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Carboxypeptidase B2 CHEMBL3419 | IC50 | 10.6 | 8.04 | 0.0 | 2 |
| Carboxypeptidase B CHEMBL4065 | IC50 | 8.82 | 8.82 | 1.5 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Carboxypeptidase B2 | IC50 | = | 0.025 | nM | 10.6 | Inhibition of human activated TAFI using Hip-Arg as substrate incubated for 10 m... | 22891675 |
| Carboxypeptidase B | IC50 | = | 1.5 | nM | 8.82 | Inhibition of pig pancreatic carboxypeptidase B using Hip-Arg as substrate incub... | 22891675 |
| Carboxypeptidase B2 | IC50 | = | 3300.0 | nM | 5.48 | Inhibition of human activated TAFI using Hip-Arg as substrate incubated for 10 m... | 22891675 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 22891675 | 10.1021/jm300735t | Carboxypeptidase B2 | 3 |
| 22891675 | 10.1021/jm300735t | Unchecked | 3 |
| 22891675 | 10.1021/jm300735t | Carboxypeptidase B | 2 |
Data from ChEMBL 36 via Core Engine